Why the study?
Does rivaroxaban with or without vitamin K2 supplementation reduce progression of vascular calcification compared to vitamin K antagonists in chronic haemodialysis patients with non-valvular atrial fibrillation?
Population
117 chronic haemodialysis patients with non-valvular atrial fibrillation, treated with or candidates for…
Comparison
Rivaroxaban 10 mg daily, or rivaroxaban 10 mg… vs Vitamin K antagonist titrated weekly to an…
Design
Randomized, open-label
Follow-up
18 months
Authors
Loading...
No results yet; leaves open whether rivaroxaban ± vitamin K2 slows vascular calcification versus vitamin K antagonists in hemodialysis AF.
Does rivaroxaban with or without vitamin K2 supplementation reduce progression of vascular calcification compared to vitamin K antagonists in chronic haemodialysis patients with non-valvular atrial fibrillation?
Ongoing trials will determine if vitamin K supplementation or substitution of vitamin K antagonists with rivaroxaban can mitigate vascular calcification in hemodialysis patients.
Caluwé et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: